• 中国精品科技期刊
  • 中国高校百佳科技期刊
  • 中国中文核心期刊
  • 中国科学引文数据库核心期刊
Advanced Search
HE Mingzhe, PENG Ying, WANG Guangji, A Jiye, ZHENG Yiwen, SUN Jianguo. Mechanism of sodium salicylate-induced damage to HEI-OC1 cells based on metabonomics[J]. Journal of China Pharmaceutical University, 2021, 52(5): 566-572. DOI: 10.11665/j.issn.1000-5048.20210508
Citation: HE Mingzhe, PENG Ying, WANG Guangji, A Jiye, ZHENG Yiwen, SUN Jianguo. Mechanism of sodium salicylate-induced damage to HEI-OC1 cells based on metabonomics[J]. Journal of China Pharmaceutical University, 2021, 52(5): 566-572. DOI: 10.11665/j.issn.1000-5048.20210508
shu

Mechanism of sodium salicylate-induced damage to HEI-OC1 cells based on metabonomics

  • 1.

    Key Laboratory of Drug Metabolism and Pharmacokinetics, China Pharmaceutical University, Nanjing 210009, China

  • 2.

    Department of Pharmacology and Toxicology, School of Biomedical Sciences, University of Otago, Dunedin 9054, New Zealand

Funds: This study was supported by the National Key Research and Development Program for Intergovernmental Cooperation in International Science and Technology Innovation (No.2017YFE0109600)
More Information
  • Received Date: April 06, 2021
  • Revised Date: September 13, 2021
    Graphical Abstract
    • Abstract
  • The effect of sodium salicylate on the endogenous metabolism of hair cell-like cells (HEI-OC1).of mice was analyzed based on liquid chromatography-quadrupole time of flight mass spectrometry (LC-Q-TOF/MS).Firstly, HEI-OC1 cells were treated with different concentrations of sodium salicylate, and cell survival was examined by the CCK-8 method. Next, sodium salicylate was administered for different duration to observe the changes in cell morphology. Inter-group differential metabolites were screened out, and the associated metabolic pathways were analyzed based on metabonomic technology.Results showed that sodium salicylate could significantly inhibit the survival rate of HEI-OC1 cells, and that, as the concentration increased, the inhibitory effect became stronger. Also, the cell morphology could be elongated after administration and return to normal after withdrawal.Eighteen differential metabolites such as orotic acid, uridine and aspartic acid were screened out after treatment of sodium salicylate, which mainly involving two possible metabolic pathways, namely the metabolism of alanine, aspartic acid and glutamic acid, and that of pyrimidine.In summary, the application of metabolomics technology to evaluate the effect of sodium salicylate on hair cells from the microscopic perspective can provide new ideas for the study of sodium salicylate ototoxicity and development of tinnitus.
    • FullText(HTML)
    • References (18)
  • [1]
    . Curr Med Res Opin，2011，27（8）：1635-1643.
    [2]
    Bhatt JM，Lin HW，Bhattacharyya N. Prevalence，severity，exposures，and treatment patterns of tinnitus in the United States［J］. JAMA Otolaryngol Head Neck Surg，2016，142（10）：959-965.
    [3]
    Galazyuk A，Brozoski TJ. Animal models of tinnitus：a review［J］. Otolaryngol Clin North Am，2020，53（4）：469-480.
    [4]
    Li SH，Han DY，Yang WY，et al. Research progress on the ototoxicity mechanism of sodium salicylate［J］. J Audiol Speech Pathol（听力学及言语疾病杂志），2001，9（3）：174-176.
    [5]
    Steffens DC，Wei Jiang，Krishnan KR，et al. Metabolomic differences in heart failure patients with and without major depression［J］. J Geriatr Psychiatry Neurol，2010，23（2）：138-146.
    [6]
    Li WW，Yang Y，Wang SC，et al. Research progress of cellular metabolomics［J］. J Nanjing Univ Tradit Chin Med（南京中医药大学学报），2017，33（2）：187-192.
    [7]
    Lu Z，Li S，Sun R，et al. Hirsutella sinensis treatment shows protective effects on renal injury and metabolic modulation in db/db mice［J］. Evid Based Complement Alternat Med，2019，2019：4732858.
    [8]
    Wang W，Cai Q，Zhou F，et al. Impaired pentose phosphate pathway in the development of 3D MCF-7 cells mediated intracellular redox disturbance and multi-cellular resistance without drug induction［J］. Redox Biol，2018，15：253-265.
    [9]
    McEvilly M，Popelas C，Tremmel B. Use of uridine triacetate for the management of fluorouracil overdose［J］. Am J Health Syst Pharm，2011，68（19）：1806-1809.
    [10]
    Gallai V，Mazzotta G，Montesi S，et al. Effects of uridine in the treatment of diabetic neuropathy：an electrophysiological study［J］. Acta Neurol Scand，1992，86（1）：3-7.
    [11]
    Mironova GD，Khrenov MO，Talanov EY，et al. The role of mitochondrial KATP channel in anti-inflammatory effects of uridine in endotoxemic mice［J］. Arch Biochem Biophys，2018，654：70-76.
    [12]
    Le TT，Ziemba A，Urasaki Y，et al. Disruption of uridine homeostasis links liver pyrimidine metabolism to lipid accumulation［J］. J Lipid Res，2013，54（4）：1044-1057.
    [13]
    Sun Q. Glutamate excitotoxicity and the effect of glutamate-glutamine cycle in the cochlea （耳蜗谷氨酸兴奋性毒性及谷氨酸—谷氨酰胺循环机制的研究）［D］. Beijing：PLA Postgraduate Medical School，2004.
    [14]
    Fuhrman S，Palkovits M，Cassidy M，et al. The regional distribution of N-acetylaspartylglutamate （NAAG） and peptidase activity against NAAG in the rat nervous system［J］. J Neurochem，1994，62（1）：275-281.
    [15]
    Zhao J，Ramadan E，Cappiello M，et al. NAAG inhibits KCl-induced［3H］-GABA release via mGluR3，cAMP，PKA and L-type calcium conductance［J］. Eur J Neurosci，2001，13（2）：340-346.
    [16]
    Sanabria ER，Wozniak KM，Slusher BS，et al. GCP II （NAALADase） inhibition suppresses mossy fiber-CA3 synaptic neurotransmission by a presynaptic mechanism［J］. J Neurophysiol，2004，91（1）：182-193.
    [17]
    Romei C，Raiteri M，Raiteri L. Glycine release is regulated by metabotropic glutamate receptors sensitive to mGluR2/3 ligands and activated by N-acetylaspartylglutamate （NAAG）［J］. Neuropharmacology，2013，66：311-316.
    [18]
    Fulop T，Radabaugh S，Smith C. Activity-dependent differential transmitter release in mouse adrenal chromaffin cells［J］. J Neurosci，2005，25（32）：7324-7332.
    • Related Articles

  • Related Articles

    [1]WANG Jingqi, WANG Ye, ZHANG Yi, LIANG Juncheng, DENG Yanping, HANG Taijun, SONG Min. Metabolomic study on clinical staging of methamphetamine detoxification by LC-QTOF-MS[J]. Journal of China Pharmaceutical University, 2022, 53(3): 314-322. DOI: 10.11665/j.issn.1000-5048.20220309
    [2]ZHANG Liuxiao, OBORE Nathan, YU Tianyi, QIAN Huiqin, ZHANG Yuan, YU Hong. Research progress in biological markers of perinatal depression[J]. Journal of China Pharmaceutical University, 2022, 53(1): 120-124. DOI: 10.11665/j.issn.1000-5048.20220118
    [3]LI Xiaoshi, WU Xunxun, ZHENG Zuguo, YANG Hua, LI Ping. Advances of long noncoding RNAs in myocardial fibrosis[J]. Journal of China Pharmaceutical University, 2020, 51(6): 646-654. DOI: 10.11665/j.issn.1000-5048.20200602
    [4]WU Yubing, YIN Lifang, QIN Chao. Clinical application and detection of matrix metalloproteinases in diagnosis[J]. Journal of China Pharmaceutical University, 2020, 51(5): 614-621. DOI: 10.11665/j.issn.1000-5048.20200514
    [5]MU Jinming, LIU Yue, ZHANG Fangfang, JIN Liang. Relationship between circular RNA and type 2 diabetes and its clinical application[J]. Journal of China Pharmaceutical University, 2020, 51(3): 374-378. DOI: 10.11665/j.issn.1000-5048.20200316
    [6]TAO Yingjun, WU Jie, LIU Chang. Application of proteomics in diabetes and its complications[J]. Journal of China Pharmaceutical University, 2020, 51(3): 368-373. DOI: 10.11665/j.issn.1000-5048.20200315
    [7]YIN Kunpeng, ZHENG Hao, XIE Binxin, LI Ping, ZHANG Lei, FAN Yong, ZHU Wei, QI Lianwen. Clinical metabolomics in diagnosis and therapy of coronary artery disease[J]. Journal of China Pharmaceutical University, 2017, 48(6): 629-634. DOI: 10.11665/j.issn.1000-5048.20170601
    [8]ZHANG Xue, WANG Yuhao, ZHENG Yunsi, HE Hua, LIU Xiaoquan. Evaluation of the protective effect of salvianolic acid A on ischemic heart failure by a multi-target pharmacokinetic-pharmacodynamic model[J]. Journal of China Pharmaceutical University, 2016, 47(5): 587-594. DOI: 10.11665/j.issn.1000-5048.20160514
    [9]LI Chen, YUAN Linhua, MA Xueqin, LIU Xiaoquan, XI Tao. Variation of cardiovascular risk biomarkers in type 2 diabetes mellitus[J]. Journal of China Pharmaceutical University, 2013, 44(3): 257-262. DOI: 10.11665/j.issn.1000-5048.20130314
    [10]HUANG Yin, XU Fengguo, ZHANG Wei, ONG Choonnam, ZHANG Zunjian. Progress for pharmacometabolomics and its applications[J]. Journal of China Pharmaceutical University, 2013, 44(2): 105-112. DOI: 10.11665/j.issn.1000-5048.20130202

  • Cited by

    Periodical cited type(0)

    Other cited types(1)

Catalog

    Get Citation
    PDF
    XML
    Article views (177) PDF downloads (465) Cited by(1)
    Turn off MathJax
    Article Contents
    Abstract
    References
    Related Articles

    Copyright © Journal of China Pharmaceutical University苏ICP备12050101号-2

    Address：24 Tongjia Lane, Nanjing City, Jiangsu Province （210009）Tel: 025-83271566E-mail: xuebao@cpu.edu.cn

    Supported by: Beijing Renhe Information Technology Co., Ltd.  Baidu Analytics

    Total visits：300499

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return